Dutch Court Sides With Teva In Spat Over MS Drug Patent
A Dutch court has rebuffed a bid by Mylan Laboratories Inc. to have Teva Pharmaceutical Industries Ltd.'s patent for its multiple sclerosis drug Copaxone declared invalid, the latter company announced Thursday....To view the full article, register now.
Already a subscriber? Click here to view full article